Home Biosimilar Antibodies Immunology & Inflammation PD-1/PD-L1 antibody Manelimab (Anti-B7-H1 / PD-L1 / CD274) For research use only.
Not for use in humans.

Manelimab (Anti-B7-H1 / PD-L1 / CD274)

Synonyms: BCD-135

Manelimab (Anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 143.68 kD.

Manelimab (Anti-B7-H1 / PD-L1 / CD274)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Manelimab (Anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 143.68 kD.

Product Details

CAS No. 2168561-26-8
Molecular Weight 143.68
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Manelimab (Anti-B7-H1 / PD-L1 / CD274) | Manelimab (Anti-B7-H1 / PD-L1 / CD274) supplier | purchase Manelimab (Anti-B7-H1 / PD-L1 / CD274) | Manelimab (Anti-B7-H1 / PD-L1 / CD274) cost | Manelimab (Anti-B7-H1 / PD-L1 / CD274) manufacturer | order Manelimab (Anti-B7-H1 / PD-L1 / CD274) | Manelimab (Anti-B7-H1 / PD-L1 / CD274) distributor